Table 1. Demographic and baseline characteristics of both study groups.
| Variable | POAG(a) (n=20) | Control(b) (n=25) | p-value |
|---|---|---|---|
| Age (years)(c) |
71.1±6.3 |
70.8±6.5 |
0.97(d) |
| Sex n (%) | |||
| Female |
9 (45%) |
12 (48%) |
0.56(e) |
| Male |
11 (55%) |
13 (52%) |
|
| BMI (kg/m2)(f)(c) |
25.56±4.26 |
25.35±4.12 |
0.52(d) |
| Intraocular pressure (mm Hg) |
25.50±3.73 |
14.23±1.24 |
0.04(d) |
| Medical therapy |
n (%) |
|
|
| 2 drops(g) |
6 (30%) |
- |
|
| 3 drops(h) |
6 (30%) |
- |
|
| 4 drops(i) |
8 (40%) |
- |
|
| Cup-to-disc ratio (% of patients) |
0.6 (30%) |
- |
|
| |
0.7 (15%) |
- |
|
| |
0.8 (20%) |
- |
|
| ≥0.9 (35%) | - | ||
(a)Primary open-angle glaucoma. (b)Senile cataract patients. (c)Data are expressed as mean±SD (d)Performed by Mann–Whitney U test. (e)Performed by χ2. (f)Body mass index. (g)Timolol + Latanoprost. (h)Timolol + Dorzolamide + Latanoprost. (i)Timolol + Dorzolamide + Latanoprost + Brimonidine.